Ileal Interposition in Rats with Experimental Type 2 Like Diabetes Improves Glycemic Control Independently of Glucose Absorption

Journal of Diabetes Research

Volumn 2015, Issue , 2015, Pages

  Jurowich, Christian Ferdinand ^a   Otto, Christoph ^a   Rikkala, Prashanth Reddy ^b   Wagner, Nicole ^b   Vrhovac, Ivana ^c   Sabolić, Ivan ^c   Germer, Christoph Thomas ^a   Koepsell, Hermann ^b,d  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c INSTITUTE FOR MEDICAL RESEARCH AND OCCUPATIONAL HEALTH   (Croatia)

^d UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; SODIUM GLUCOSE COTRANSPORTER 1; GLUCOSE; GLUCOSE BLOOD LEVEL; SLC5A1 PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BARIATRIC SURGERY; CONTROLLED STUDY; GLUCOSE ABSORPTION; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; GLYCEMIC CONTROL; HYPERPLASIA; ILEUM; INSULIN SENSITIVITY; JEJUNUM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STOMACH BYPASS; ANALYSIS; ANIMAL; BLOOD; COMPLICATION; ENTEROENDOCRINE CELL; GERMFREE ANIMAL; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN RESISTANCE; INTESTINE ABSORPTION; LEWIS RAT; MALE; METABOLISM; MICROVILLUS; OBESITY; PATHOLOGY; SECRETION (PROCESS); ULTRASTRUCTURE;

ANIMALS; BARIATRIC SURGERY; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; ENTEROENDOCRINE CELLS; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; HYPERGLYCEMIA; HYPERPLASIA; HYPOGLYCEMIA; ILEUM; INSULIN RESISTANCE; INTESTINAL ABSORPTION; MALE; MICROVILLI; OBESITY; RATS, INBRED LEW; SODIUM-GLUCOSE TRANSPORTER 1; SPECIFIC PATHOGEN-FREE ORGANISMS;

EID: 84936818527     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2015/490365     Document Type: Article

References (68)

1. J. E. Shaw, R. A. Sicree, and P. Z. Zimmet, "Global estimates of the prevalence of diabetes for 2010 and 2030, " Diabetes Research and Clinical Practice, vol. 87, no. 1, pp. 4-14, 2010.
2. H. Buchwald, R. Estok, K. Fahrbach et al., "Weight and type 2 diabetes afer bariatric surgery: systematic review and meta-analysis, " Te American Journal of Medicine, vol. 122, no. 3, pp. 248-256, 2009.
3. N. V. Christou, J. S. Sampalis, M. Liberman et al., "Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients, " Annals of Surgery, vol. 240, no. 3, pp. 416-424, 2004.
4. R. E. Brolin, "Bariatric surgery and long-term control of morbid obesity, " Journal of the American Medical Association, vol. 288, no. 22, pp. 2793-2796, 2002.
5. R. Steinbrook, "Surgery for severe obesity, " Te New England Journal of Medicine, vol. 350, no. 11, pp. 1075-1079, 2004.
6. H. Ashrafan and C. W. le Roux, "Metabolic surgery and gut hormones-a review of bariatric entero-humoral modulation, " Physiology & Behavior, vol. 97, no. 5, pp. 620-631, 2009.
7. J. P. Taler and D. E. Cummings, "Minireview: hormonal and metabolic mechanisms of diabetes remission afer gastrointestinal surgery, " Endocrinology, vol. 150, no. 6, pp. 2518-2525, 2009.
8. D. E. Cummings, "Metabolic surgery for type 2 diabetes, " Nature Medicine, vol. 18, no. 5, pp. 656-658, 2012.
9. J. B. Dixon, P. Zimmet, K. G. Alberti, and F. Rubino, "Bariatric surgery: an IDF statement for obese Type 2 diabetes, " Diabetic Medicine, vol. 28, no. 6, pp. 628-642, 2011.
10. R. Cohen, J. S. Pinheiro, J. L. Correa, and C. A. Schiavon, "Laparoscopic Roux-en-Y gastric bypass for BMI <35 kg/m2: a tailored approach, " Surgery for Obesity and Related Diseases, vol. 2, no. 3, pp. 401-404, 2006.
11. C. F. Jurowich, P. R. Rikkala, A. Talheimer et al., "Duodenal-jejunal bypass improves glycemia and decreases SGLT1-mediated glucose absorption in rats with streptozotocin-induced type 2 diabetes, " Annals of Surgery, vol. 258, no. 1, pp. 89-97, 2013.
12. H. S. Koopmans, A. Sclafani, C. Fichtner, and P. F. Aravich, "Te efects of ileal transposition on food intake and body weight loss in VMH-obese rats, " Te American Journal of Clinical Nutrition, vol. 35, no. 2, pp. 284-293, 1982.
13. A. Patriti, E. Facchiano, C. Annetti et al., "Early improvement of glucose tolerance afer ileal transposition in a non-obese type 2 diabetes rat model, " Obesity Surgery, vol. 15, no. 9, pp. 1258-1264, 2005.
14. M. K. Badman and J. S. Flier, "Te gut and energy balance: visceral allies in the obesity wars, " Science, vol. 307, no. 5717, pp. 1909-1914, 2005.
15. K. G. Murphy and S. R. Bloom, "Gut hormones and the regulation of energy homeostasis, " Nature, vol. 444, no. 7121, pp. 854-859, 2006.
16. K. Chandarana and R. L. Batterham, "Shedding pounds afer going under the knife: metabolic insights from cutting the gut, " Nature Medicine, vol. 18, no. 5, pp. 668-669, 2012.
17. A. S. Rocca and P. L. Brubaker, "Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion, " Endocrinology, vol. 140, no. 4, pp. 1687-1694, 1999.
18. D. M. Breen, B. A. Rasmussen, A. Kokorovic, R. Wang, G. W. C. Cheung, and T. K. T. Lam, "Jejunal nutrient sensing is required for duodenal-jejunal bypass surgery to rapidly lower glucose concentrations in uncontrolled diabetes, " Nature Medicine, vol. 18, no. 6, pp. 950-955, 2012.
19. J. E. Ayala, D. P. Bracy, F. D. James, B. M. Julien, D. H. Wasser-man, and D. J. Drucker, "Te glucagon-like peptide-1 receptor regulates endogenous glucose production and muscle glucose uptake independent of its incretin action, " Endocrinology, vol. 150, no. 3, pp. 1155-1164, 2009.
20. W. Chai, Z. Dong, N. Wang et al., "Glucagon-like peptide 1 recruits microvasculature and increases glucose use in muscle via a nitric oxide-dependent mechanism, " Diabetes, vol. 61, no. 4, pp. 888-896, 2012.
21. J. J. Holst, "Glucagon-like peptide 1 (GLP-1): an intestinal hormone, signalling nutritional abundance, with an unusual therapeutic potential, " Trends in Endocrinology & Metabolism, vol. 10, no. 6, pp. 229-235, 1999.
22. N. Imeryuz, B. C. Yegen, A. Bozkurt, T. Coskun, M. L. Villan-ueva-Penacarrillo, and N. B. Ulusoy, "Glucagon-like peptide-1 inhibits gastric emptying via vagal aferent-mediated central mechanisms, " Te American Journal of Physiology: Gastrointestinal and Liver Physiology, vol. 273, no. 36, pp. G920-G927, 1997.
23. C. Tomas, A. Gioiello, L. Noriega et al., "TGR5-mediated bile acid sensing controls glucose homeostasis, " Cell Metabolism, vol. 10, no. 3, pp. 167-177, 2009.
24. E. M. Wright, D. D. F. L. LOO, and B. A. Hirayama, "Biology of human sodium glucose transporters, " Physiological Reviews, vol. 91, no. 2, pp. 733-794, 2011.
25. V. Gorboulev, A. Schürmann, V. Vallon et al., "Na+-d-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion, " Diabetes, vol. 61, no. 1, pp. 187-196, 2012.
26. T. T. Wang, S. Y. Hu, H. D. Gao et al., "Ileal transposition controls diabetes as well as modifed duodenal jejunal bypass with better lipid lowering in a nonobese rat model of type II diabetes by increasing GLP-1, " Annals of Surgery, vol. 247, no. 6, pp. 968-975, 2008.
27. C. Hu, G. Zhang, D. Sun, H. Han, and S. Hu, "Duodenal-jejunal bypass improves glucose metabolism and adipokine expression independently of weight loss in a diabetic rat model, " Obesity Surgery, vol. 23, no. 9, pp. 1436-1444, 2013.
28. S.-Z. Liu, D. Sun, G.-Y. Zhang et al., "A high-fat diet reverses improvement in glucose tolerance induced by duodenal-jejunal bypass in type 2 diabetic rats, " Chinese Medical Journal, vol. 125, no. 5, pp. 912-919, 2012.
29. H. S. Koopmans, G.-L. Ferri, D. L. Sarson, J. M. Polak, and S. R. Bloom, "Te efects of ileal transposition and jejunoileal bypass on food intake and GI hormone levels in rats, " Physiology & Behavior, vol. 33, no. 4, pp. 601-609, 1984.
30. P. K. Chelikani, I. H. Shah, E. Taqi, D. L. Sigalet, and H. H. Koopmans, "Comparison of the efects of Roux-en-Y gastric bypass and ileal transposition surgeries on food intake, body weight, and circulating peptide YY concentrations in rats, " Obesity Surgery, vol. 20, no. 9, pp. 1281-1288, 2010.
31. M. Mokadem, J. F. Zechner, R. F. Margolskee, D. J. Drucker, and V. Aguirre, "Efects of Roux-en-Y gastric bypass on energy and glucose homeostasis are preserved in two mouse models of functional glucagon-like peptide-1 defciency, " Molecular Metabolism, vol. 3, no. 2, pp. 191-201, 2014.
32. E. Taqi, L. E. Wallace, E. de Heuvel et al., "Te infuence of nutrients, biliary-pancreatic secretions, and systemic trophic hormones on intestinal adaptation in a Roux-en-Y bypass model, " Journal of Pediatric Surgery, vol. 45, no. 5, pp. 987-995, 2010.
33. H. Zheng, A. C. Shin, N. R. Lenard et al., "Meal patterns, satiety, and food choice in a rat model of Roux-en-Y gastric bypass surgery, " Te American Journal of Physiology-Regulatory Inte-grative and Comparative Physiology, vol. 297, no. 5, pp. R1273-R1282, 2009.
34. D. E. Cummings, D. S. Weigle, R. Scott Frayo et al., "Plasma ghrelin levels afer diet-induced weight loss or gastric bypass surgery, " Te New England Journal of Medicine, vol. 346, no. 21, pp. 1623-1630, 2002.
35. M. Bueter, C. Löwenstein, T. Olbers et al., "Gastric bypass increases energy expenditure in rats, " Gastroenterology, vol. 138, no. 5, pp. 1845.e1-1853.e1, 2010.
36. C. W. le Roux, C. Borg, K. Wallis et al., "Gut hypertrophy afer gastric bypass is associated with increased glucagon-like peptide 2 and intestinal crypt cell proliferation, " Annals of Surgery, vol. 252, no. 1, pp. 50-56, 2010.
37. S. Nausheen, I. H. Shah, A. Pezeshki, D. L. Sigalet, and P. K. Chelikani, "Efects of sleeve gastrectomy and ileal transposition, alone and in combination, on food intake, body weight, gut hormones, and glucose metabolism in rats, " Te American Journal of Physiology-Endocrinology and Metabolism, vol. 305, no. 4, pp. E507-E518, 2013.
38. G. Y. Zhang, T. T. Wang, Z. Q. Cheng, J. B. Feng, and S. Y. Hu, "Resolution of diabetes mellitus by ileal transposition compared with biliopancreatic diversion in a nonobese animal model of type 2 diabetes, " Canadian Journal of Surgery, vol. 54, no. 4, pp. 243-251, 2011.
39. A. Patriti, M. C. Aisa, C. Annetti et al., "How the hindgut can cure type 2 diabetes. Ileal transposition improves glucose metabolism and beta-cell function in Goto-kakizaki rats through an enhanced Proglucagon gene expression and L-cell number, " Surgery, vol. 142, no. 1, pp. 74-85, 2007.
40. A. D. Strader, T. P. Vahl, R. J. Jandacek, S. C. Woods, D. A. D'Alessio, and R. J. Seeley, "Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats, " American Journal of Physiology-Endocrinology and Metabolism, vol. 288, no. 2, pp. E447-E453, 2005.
41. D. C. Chen, J. S. Stern, and R. L. Atkinson, "Efects of ileal transposition on food intake, dietary preference, and weight gain in Zucker obese rats, " Te American Journal of Physiology-Regulatory Integrative and Comparative Physiology, vol. 258, no. 1, pp. R269-R273, 1990.
42. A. D. Strader, T. R. Clausen, S. Z. Goodin, and D. Wendt, "Ileal interposition improves glucose tolerance in low dose streptozotocin-treated diabetic and euglycemic rats, " Obesity Surgery, vol. 19, no. 1, pp. 96-104, 2009.
43. S. Gaitonde, R. Kohli, and R. Seeley, "Te role of the gut hormone GLP-1 in the metabolic improvements caused by ileal transposition, " Journal of Surgical Research, vol. 178, no. 1, pp. 33-39, 2012.
44. J. M. Grueneberger, I. Karcz-Socha, T. Sawczyn et al., "Systematic ileal transposition in Zucker rats shows advantage for long segment distal transposition, " Surgery, vol. 155, no. 1, pp. 165-172, 2014.
45. Z. Yan, W. Chen, S. Liu, G. Zhang, D. Sun, and S. Hu, "Myocar-dial insulin signaling and glucose transport are up-regulated in Goto-Kakizaki type 2 diabetic rats afer ileal transposition, " Obesity Surgery, vol. 22, no. 3, pp. 493-501, 2012.
46. A. R. Ramzy, S. Nausheen, and P. K. Chelikani, "Ileal transposition surgery produces ileal length-dependent changes in food intake, body weight, gut hormones and glucose metabolism in rats, " International Journal of Obesity, vol. 38, no. 3, pp. 379-387, 2014.
47. D. M. Culnan, V. Albaugh, M. Sun, C. J. Lynch, C. H. Lang, and R. N. Cooney, "Ileal interposition improves glucose tolerance and insulin sensitivity in the obese Zucker rat, " American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 299, no. 3, pp. G751-G760, 2010.
48. B. P. Cummings, A. D. Strader, K. L. Stanhope et al., "Ileal interposition surgery improves glucose and lipid metabolism and delays diabetes onset in the UCD-T2DM rat, " Gastroenterology, vol. 138, no. 7, pp. 2437.e1-2446.e1, 2010.
49. Y.-S. Lee, S. Shin, T. Shigihara et al., "Glucagon-like peptide-1 gene therapy in obese diabetic mice results in long-term cure of diabetes by improving insulin sensitivity and reducing hepatic gluconeogenesis, " Diabetes, vol. 56, no. 6, pp. 1671-1679, 2007.
50. C. M. Borg, C. W. L. Roux, M. A. Ghatei, S. R. Bloom, and A. G. Patel, "Biliopancreatic diversion in rats is associated with intestinal hypertrophy and with increased GLP-1, GLP-2 and PYY levels, " Obesity Surgery, vol. 17, no. 9, pp. 1193-1198, 2007.
51. C. Stock-Damge, M. Aprahamian, F. Raul, J. Marescaux, and N. Scopinaro, "Small-intestinal and colonic changes afer bil-iopancreatic bypass for morbid obesity, " Scandinavian Journal of Gastroenterology, vol. 21, no. 9, pp. 1115-1123, 1986.
52. N. Saeidi, L. Meoli, E. Nestoridi et al., "Reprogramming of intestinal glucose metabolism and glycemic control in rats afer gastric bypass, " Science, vol. 341, no. 6144, pp. 406-410, 2013.
53. T. Shibazaki, M. Tomae, Y. Ishikawa-Takemura et al., "KGA-2727, a novel selective inhibitor of a high-afnity sodium glucose cotransporter (SGLT1), exhibits antidiabetic efcacy in rodent models, " Journal of Pharmacology and Experimental Terapeutics, vol. 342, no. 2, pp. 288-296, 2012.
54. D. R. Powell, M. Smith, J. Greer et al., "LX4211 increases serum glucagon-like peptide 1 and peptide YY levels by reducing sodium/glucose cotransporter 1 (SGLT1)-mediated absorption of intestinal glucose, " Journal of Pharmacology and Experimental Terapeutics, vol. 345, no. 2, pp. 250-259, 2013.
55. M. Bollen, S. Keppens, and W. Stalmans, "Specifc features of glycogen metabolism in the liver, " Biochemical Journal, vol. 336, no. 1, pp. 19-31, 1998.
56. J. Girard, P. Ferŕe, and F. Foufelle, "Mechanisms by which carbohydrates regulate expression of genes for glycolytic and lipogenic enzymes, " Annual Review of Nutrition, vol. 17, pp. 325-352, 1997.
57. L. Agius, "Glucokinase and molecular aspects of liver glycogen metabolism, " Biochemical Journal, vol. 414, no. 1, pp. 1-18, 2008.
58. R. L. Atkinson, J. H. Whipple, S. H. Atkinson, and C. C. Stewart, "Role of the small bowel in regulating food intake in rats, " Te American Journal of Physiology-Regulatory Integrative and Comparative Physiology, vol. 11, no. 3, pp. R429-R433, 1982.
59. K. Srinivasan, B. Viswanad, L. Asrat, C. L. Kaul, and P. Ramarao, "Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening, " Pharmacological Research, vol. 52, no. 4, pp. 313-320, 2005.
60. A. Junod, A. E. Lambert, W. Staufacher, and A. E. Renold, "Diabetogenic action of streptozotocin: relationship of dose to metabolic response, " Te Journal of Clinical Investigation, vol. 48, no. 11, pp. 2129-2139, 1969.
61. D. Balen, M. Ljubojevíc, D. Breljak et al., "Revised immunolo-calization of the Na+-D-glucose cotransporter SGLT1 in rat organs with an improved antibody, " American Journal of Physiology-Cell Physiology, vol. 295, no. 2, pp. C475-C489, 2008.
62. R. Kohli, M. Kirby, K. D. R. Setchell et al., "Intestinal adaptation afer ileal interposition surgery increases bile acid recycling and protects against obesity-related comorbidities, " Te American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 299, no. 3, pp. G652-G660, 2010.
63. M. H. Ulshen and C. A. Herbst, "Efect of proximal transposition of the ileum on mucosal growth and enzyme activity in orally nourished rats, " Te American Journal of Clinical Nutrition, vol. 42, no. 5, pp. 805-814, 1985.
64. H. Johannessen, Y. Kodama, C.-M. Zhao et al., "Eating behavior and glucagon-like peptide-1-producing cells in interposed ileum and pancreatic islets in rats subjected to ileal interposition associated with sleeve gastrectomy, " Obesity Surgery, vol. 23, no. 1, pp. 39-49, 2013.
65. S. Colagiuri, "Diabesity: therapeutic options, " Diabetes, Obesity and Metabolism, vol. 12, no. 6, pp. 463-473, 2010.
66. R. L. Prigeon, S. Quddusi, B. Paty, and D. A. D'Alessio, "Suppression of glucose production by GLP-1 independent of islet hormones: a novel extrapancreatic efect, " American Journal of Physiology-Endocrinology and Metabolism, vol. 285, no. 4, pp. E701-E707, 2003.
67. T. Zhao, P. Parikh, S. Bhashyam et al., "Direct efects of gluc-agon-like peptide-1 on myocardial contractility and glucose uptake in normal and postischemic isolated rat hearts, " Journal of Pharmacology and Experimental Terapeutics, vol. 317, no. 3, pp. 1106-1113, 2006.
68. A. T. Stearns, A. Balakrishnan, and A. Tavakkolizadeh, "Impact of Roux-en-Y gastric bypass surgery on rat intestinal glucose transport, " Te American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 297, no. 5, pp. G950-G957, 2009. http://dx.doi.org/10.1155/2015/741731